HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.

Abstract
The pharmacokinetics, biodistribution and efficacy of the radiopharmaceutical 131I-meta-iodobenzylguanidine (131I-mIBG) were determined in murine xenografts of two human neuroblastoma cell lines, SK-N-SH and SK-N-BE(2c). These lines have similar capacities in vitro for active uptake of 131I-mIBG, but different radiobiological characteristics. Groups of four mice were killed after injection of 131I-mIBG, and retained radioactivity in the tumour and normal tissues was measured at 8, 16, 24 and 48 h. Within each type there was heterogeneity of tumour uptake, although average values were similar for both. The per cent injected dose per gram of tumour retained at 24 h was (mean and 95% confidence interval) 0.95 (0.67-1.23) for SK-N-SH and 0.76 (0.47-1.05) for SK-N-BE(2c). The growth of tumours in groups of seven animals following injection of 35, 70 or 105 MBq 131I-mIBG was compared with that of controls. The specific regrowth delay (median and 95% confidence intervals) caused by 105 MBq 131I-mIBG was 4.2 (0.9-5.9) in SK-N-SH and 5.6 (0-11.3) in SK-N-BE(2c) bearing mice. SK-N-BE(2c) xenografts were significantly more sensitive to external beam irradiation than SK-N-SH xenografts.
AuthorsM N Gaze, T G Hamilton, R J Mairs
JournalThe British journal of radiology (Br J Radiol) Vol. 67 Issue 798 Pg. 573-8 (Jun 1994) ISSN: 0007-1285 [Print] England
PMID8032811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Iodine Radioisotopes
  • Iodobenzenes
  • 3-Iodobenzylguanidine
Topics
  • 3-Iodobenzylguanidine
  • Animals
  • Antineoplastic Agents (pharmacokinetics)
  • Female
  • Iodine Radioisotopes (pharmacokinetics, therapeutic use)
  • Iodobenzenes (pharmacokinetics, therapeutic use)
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neuroblastoma (metabolism, pathology, radiotherapy)
  • Radiotherapy Dosage
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: